The increased release of IL-1 cytokines occurred simultaneously to an increase of ASC speck formation and activation of caspase-1 on LPS-treated monocytes from APLAID and CAPS patients when compared with monocytes from healthy individuals (Fig. 4b). The gene discussed is IL1A; the disease is autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.